IndiaInfoline » Markets » NATCOPHARM

Natco Pharma Ltd - Share Price

NATCOPHARM

Open

472.05

Prev. Close

477.05

Turnover (lac.)

640

Day's High

508.90

Day's Low

472.05

52 Week's High

738.10

52 Week's Low

402.55

Book Value

216

Face Value

2

Mkt Cap (Cr.)

9,037

P/E

18.22

EPS

27.29

Divi. Yield

1.27

Natco Pharma LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Natco Pharma LtdNews & Updates

Meeting Type

Meeting Date

Resolution Type Description Of Resolution IiAS Recommendation

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd338.2525.9781,133.51468.760.812,920.8398.33
Divis Laboratories Ltd1,862.5538.8749,377.16360.730.861,390.49266.77
Dr Reddys Laboratories Ltd2,916.5018.3848,472.40521.700.693,032.20852.65
Biocon Ltd277.70109.7833,330.00120.700.18501.3060.94
Cipla Ltd407.6514.0332,930.68282.220.732,821.92209.71

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Natco Pharma LtdSummary & Reports

No Company Summary found

Registered Office

Natco House,Road No 2 Banjara Hills,Hyderabad, Telangana,500033

Tell. : +91-040-23547532
Website : http://www.natcopharma.co.in
Email : investors@natcopharma.co.in

Registrar Office

12-10-167, Bharath Nagar, Hyderbad - 500018 INDIA

Tell. : +91-040-23818475/76/2
Website : www.vccilindia.com
Email : info@vccilindia.com

View

- <

Reco. Price

Mar 09,2020 08:58 AM

Target Price

Target Returns:

0.00%

Result Express

Natco Pharma Ltd's Q2FY19 consolidated net profit rises 115.17% yoy to Rs181.60cr : Misses Estimates

Mar 30, 2020 07:26 AM

The company’s consolidated revenue stood at Rs543.50cr, up 27.37% yoy and 0.91% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Dividend

    Annc. Date

    12 Feb 2020

    Effective. Date

    24 Feb 2020

    Divi. Type

    Interim 3

    Divi.(%)

    175

    Divi. Amt.

    3.5

    The Board of Directors of the Company at their meeting held on 12/2/2020 have declared 3rd Interim D... More

  • Purpose

    Board Meeting

    Exp. Date

    12 Feb 2020

    Annc. Date

    03 Feb 2020

    NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is sched... More

  • Purpose

    Dividend

    Annc. Date

    12 Nov 2019

    Effective. Date

    21 Nov 2019

    Divi. Type

    Interim 2

    Divi.(%)

    50

    Divi. Amt.

    1

    Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on ... More